Jeff Yass’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.08M Buy
53,400
+5,100
+11% +$544K ﹤0.01% 4406
2026
Q2
$5.36M Buy
48,300
+34,800
+258% +$3.15M ﹤0.01% 4475
2026
Q1
$1.17M Sell
13,500
-4,500
-25% -$438K ﹤0.01% 7469
2025
Q4
$1.93M Sell
18,000
-91,700
-84% -$9.7M ﹤0.01% 5741
2025
Q3
$11.1M Sell
109,700
-23,800
-18% -$2.21M ﹤0.01% 2909
2025
Q2
$8.44M Buy
133,500
+111,200
+499% +$6.81M ﹤0.01% 3087
2025
Q1
$1.18M Buy
22,300
+6,300
+39% +$350K ﹤0.01% 6836
2024
Q4
$896K Sell
16,000
-21,600
-57% -$1.19M ﹤0.01% 7244
2024
Q3
$1.97M Buy
37,600
+10,900
+41% +$522K ﹤0.01% 5297
2024
Q2
$1.1M Sell
26,700
-16,800
-39% -$671K ﹤0.01% 6362
2024
Q1
$1.88M Buy
43,500
+16,900
+64% +$740K ﹤0.01% 5482
2023
Q4
$1.22M Buy
26,600
+17,700
+199% +$558K ﹤0.01% 6489
2023
Q3
$204K Buy
+8,900
New +$199K ﹤0.01% 10184
2023
Q2
– Sell
-48,500
Closed -$865K – 12997
2023
Q1
$865K Buy
48,500
+8,800
+22% +$221K ﹤0.01% 7199
2022
Q4
$1.16M Sell
39,700
-62,400
-61% -$1.6M ﹤0.01% 5854
2022
Q3
$2.5M Buy
+102,100
New +$1.9M ﹤0.01% 4460
2022
Q2
– Sell
-15,700
Closed -$181K – 13813
2022
Q1
$181K Buy
+15,700
New +$138K ﹤0.01% 11359
2021
Q3
– Sell
-12,700
Closed -$249K – 13454
2021
Q2
$249K Sell
12,700
-19,500
-61% -$405K ﹤0.01% 11153
2021
Q1
$685K Sell
32,200
-115,200
-78% -$3.34M ﹤0.01% 8724
2020
Q4
$4.38M Buy
147,400
+90,700
+160% +$2.31M ﹤0.01% 3635
2020
Q3
$1.23M Buy
+56,700
New +$1.3M ﹤0.01% 5622

Other funds holding RYTM

Jeff Yass's RYTM Position: Q3 2026 in Review

Jeff Yass increased its Rhythm Pharmaceuticals (RYTM) stake by 432% in Q3 2026, buying an estimated $2.01M and bringing the position to 23,245 shares worth $2.21M. The position accounts for ﹤0.01% of the portfolio, ranked #6053.

Jeff Yass first reported a position in RYTM in Q2 2019 and has held it in 29 quarters since. The position peaked at $20.2M in Q4 2022. 328 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

  • Jeff Yass held 23,245 shares of Rhythm Pharmaceuticals worth $2.21M as of Q3 2026.
  • Jeff Yass bought 18,873 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $2.01M.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #6053 holding.
  • Jeff Yass first reported a position in Rhythm Pharmaceuticals in Q2 2019 and has held it in 29 quarters since.
  • Jeff Yass's Rhythm Pharmaceuticals position peaked at $20.2M in Q4 2022.
  • 328 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.